Skip to Main Content

Paper Details

Optimizing preclinical pediatric low-grade glioma models for meaningful clinical translation.
Neuro Oncol
3
2023
ERK, MEK, Pediatric low-grade gliomas, T cells, brain tumor, brain tumors, central nervous system tumors, children, low-grade glioma, microglia, neoplastic, neoplastic cell, neurological symptoms, neurons, nonneoplastic cells, pLGG, pLGGs, tumor, tumors
Author NameAffiliation
Till MildeHopp Children's Cancer Center Heidelberg (KiTZ)
Till MildeClinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK)
Till MildeKiTZ Clinical Trial Unit (ZIPO), Heidelberg University Hospital
Till MildeNational Center for Tumor Diseases (NCT)
Jason FangusaroEmory University School of Medicine
Cynthia HawkinsHospital for Sick Children
Cynthia HawkinsHospital for Sick Children
Fausto J RodriguezUniversity of California Los Angeles
Fausto J RodriguezUniversity of California Los Angeles
Uri TaboriInstitute of Medical Science and Paediatrics, University of Toronto
Olaf WittHopp Children's Cancer Center Heidelberg (KiTZ)
Olaf WittClinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK)
Olaf WittKiTZ Clinical Trial Unit (ZIPO), Heidelberg University Hospital
Olaf WittNational Center for Tumor Diseases (NCT)
Olaf WittHopp Children's Cancer Center Heidelberg (KiTZ)
Olaf WittClinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK)
Olaf WittKiTZ Clinical Trial Unit (ZIPO), Heidelberg University Hospital
Olaf WittNational Center for Tumor Diseases (NCT)
David H GutmannWashington University School of Medicine
  • 1 - 19

Datasets